Integrated Diagnostics (IDHC) Share Price, News & Analysis

Company Overview

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, including positron emission tomography computed tomography (PET-CT), magnetic resonance imaging (MRI), computed tomography (CT), mammography, ultrasound, x-ray, electromyography (EMG), electroencephalography, electroencephalogram (EEG), and electrocardiogram (ECG), as well as operates cath lab facilities. It operates in Egypt, Sudan, Jordan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.

Key Stats

• Today's Range: 0.37 to 0.39
• 50-Day Range: 0.34 to 0.53
• 52-Week Range: 0.28 to 0.54
• Volume: 1,407 shs
• Average Volume: 394,011 shs
• Market Capitalization: £2.21 million
• P/E Ratio: 12.67
• Dividend Yield: 2,631.58%
• Price Target: N/A
• Consensus Rating: N/A

IDHC Stock Analysis - Frequently Asked Questions

How have IDHC shares performed this year?

Integrated Diagnostics' stock was trading at GBX 0.36 at the start of the year. Since then, IDHC shares have increased by 7.0% and is now trading at GBX 0.38.
View the best growth stocks for 2024 here.

How do I buy shares of Integrated Diagnostics?

Shares of IDHC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Integrated Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Integrated Diagnostics investors own include Georgia Healthcare Group PLC (GHG.L) (GHG), VEON (VEON), Pao Tmk (TMKXY) and M.P. Evans Group (MPE).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: LON:IDHC
• CUSIP: N/A
• CIK: N/A
• Web: www.idhcorp.com
• Phone: +44-1534-847000
• Fax: N/A
• Employees: 6,692
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.03
• Trailing P/E Ratio: 12.33
• Forward P/E Ratio: 0.26
• P/E Growth: 7.65
• Net Income: £817.28 million
• Net Margins: 17.21%
• Pretax Margin: N/A
• Return on Equity: 23.03%
• Return on Assets: 9.69%

Debt

• Debt-to-Equity Ratio: 35.86
• Current Ratio: 1.59
• Quick Ratio: 0.75

Sales & Book Value

• Annual Sales: £4.75 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: GBX 464 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 581,330,000
• Free Float: N/A
• Market Cap: £2.15 million
• Optionable: Not Optionable
• Beta: 0.59